U.S. Food et al., 2026-11-19: FDA's accelerated-approval tracking table lists Provayblue (methylene blue) for pediatric and adult acquired methemoglobinemia with an accelerated approval date of 8 April 2016 and a traditional (full) approval date of 8 January 2024.
Provayblue (methylene blue) For the treatment of pediatric and adult patients with acquired methemoglobinemia 4/8/2016 1/8/2024
U.S. Food et al., 2026-11-19: FDA's accelerated-approval tracking table lists Provayblue (methylene blue) for pediatric and adult acquired methemoglobinemia with an accelerated approval date of 8 April 2016 and a traditional (full) approval date of 8 January 2024. Study type: regulatory record.
